TP53 p.Thr284Ser
c.850A>T · rs1204379654 · VCV458571
Computational evidence
| Protein change | ||
| AlphaMissense | 0.2344 | likely benign |
|---|---|---|
| REVEL | 0.495 | indeterminate |
| SaProt | LLR -7.38 | tolerated |
| ⇒ AlphaMissense and SaProt both call this tolerated; REVEL is indeterminate. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 6.2 | GERP 0.49, phastCons 1 |
| Regional constraint | o/e 0.89 | unconstrained · MANE · 6,982 bp · p 0.0085 · regional, not allelic |
| Overall | ||
| CADD | 22.1 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| European (non-Finnish)grpmax | 0.00271% | 36,877 |
| Remaining individualsnot grpmax-eligible | 0.0016% | 62,482 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- TP53
- Protein
- p.Thr284Ser
- Coding
- c.850A>T
- MANE Select
- NM_000546
- dbSNP
- rs1204379654
- Type
- single nucleotide variant
- Location
- chr17:7673770 (GRCh38)
- Gene constraint
- LOEUF 0.449 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
- Structure
- AlphaFold pLDDT 75.83 · 321 PDB
- Residue 284
- a DNA-binding region; the 'interaction with axin1' region; the 'interaction with e4f1' region; a UniProt-annotated variant site (in sporadic cancers; somatic mutation); the 'disordered' region; an α-helix; the 'interaction with ccar2' region; a modified residue (phosphothreonine; by aurkb); the 'interaction with hipk1' region; the 'required for interaction with znf385a' region
Disease context
Li-Fraumeni syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: hereditary neoplastic syndrome
For Li-Fraumeni syndrome (Orphanet):
- Inheritance
- Autosomal dominant
- Onset
- All ages
- Prevalence
- 1-9 / 100 000 (United Kingdom)
Similar variants
- TP53 p.Thr284Ile Likely benign ★★★ same residue
- TP53 p.Thr284= Benign/Likely benign ★★ same residue
- TP53 p.Thr284Ala Conflicting classifications of pathogenicity ★ ⚠ same residue
- TP53 p.Thr284Pro Conflicting classifications of pathogenicity ★ ⚠ same residue
- TP53 p.Thr284fs Pathogenic ★ same residue
- TP53 p.Thr284_Glu285insAspProIleLeuAlaProLeuProAlaProGlyThr Uncertain significance ★ same residue
- TP53 p.Thr284Arg Uncertain significance ★ ⚠ same residue
- TP53 c.375+5G>A Likely pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/tp53-p-thr284ser (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown